Primary Factory-Direct Botanical Platforms
Verified active marker potencies from GMP-certified continuous extraction facilities. Directly accessible for enterprise supplement formulation, pharmaceutical intermediate synthesis, and international wholesale procurement.
Wholesale Epimedium Extract Suppliers, Factory
View Specifications
China Quercetin Suppliers, Factories
View Specifications
China Broccoli Seed Extract Factories, Exporter
View Specifications
Best Grape Seed Extract (GSE) Supplier, Factory
View Specifications
Best Olive Leaf Extract Exporter, Exporters
View Specifications
Best Ajuga Extract Suppliers, Exporters
View Specifications
Best Garlic Extract Factory, Exporter
View Specifications
Wholesale Pomegranate Extract Suppliers, Factory
View SpecificationsBotanical Taxonomy & The Icariin Molecular Profile
Understanding the bio-equivalence, glycosidic cleavage pathways, and chemotypic variations across commercial Berberidaceae species is fundamental for enterprise formulation engineers.
Taxonomic Differentiation
The genus Epimedium comprises more than 50 herbaceous species, but pharmacopeial compliance (CP, USP, EP) centers strictly on five authenticated taxa: Epimedium brevicornu Maxim., Epimedium sagittatum (Sieb. et Zucc.) Maxim., Epimedium pubescens Maxim., Epimedium wushanense T.S. Ying, and Epimedium koreanum Nakai. Our factory sourcing models verify genetic lineage through DNA barcoding to eliminate adulterant species that carry inadequate flavonol densities.
ITS2 Sequence & TLC AuthenticatedFlavonoid Glycoside Cascade
Icariin (8-isopentenyl-kaempferol-3,7-O-diglucoside, C33H40O15, MW 676.66 g/mol) is the primary regulated marker compound. Upon human or enzymatic metabolism, Icariin undergoes sequential deglycosylation: losing the C-7 glucose to form Icariside II (Baohuoside I), or losing C-3 rhamnose to produce Icariside I, ultimately yielding the hydrophobic aglycone Icaritin. Controlling this glycosidic ratio during industrial solid-liquid extraction defines physiological bioavailability.
CAS No. 489-32-7 · HPLC ≥ 98.0%Secondary Bioactive Flavonols
Enterprise clinical utility relies on a broad flavonol fingerprint beyond isolated Icariin. Our countercurrent extraction preserving lines standardize Epimedin A, Epimedin B, and Epimedin C alongside Total Flavonoids (calculated as Icariin via UV-Vis at 270 nm). Epimedin C content is particularly high in wild-collected E. sagittatum and serves as an irreplaceable synergistic biomarker in neuro-regenerative and osteogenic functional patents.
Total Flavonoids 10% - 60% UVChina Factory 4.0: Supply Chain Resilience & Processing Efficiency
Moving beyond rudimentary kettle boiling to continuous countercurrent extraction batteries, automated DCS-controlled resin columns, and closed-loop solvent recycling.
Qinling-Daba Cultivation Clusters
Raw material vulnerability is the Achilles heel of botanical APIs. Our supply architecture is rooted in long-term wild harvesting cooperatives and Good Agricultural and Collection Practices (GACP) wild-simulated plantation bases across the Qinling and Daba Mountain belts (Shaanxi and Sichuan provinces). These montane valleys deliver microclimates with optimal shade, soil acidity, and diurnal temperature spreads that maximize leaf flavonol synthesis while keeping environmental cadmium and lead absorption well below European Union limits.
- GPS-logged collection zones ensuring raw traceability
- Pre-harvest leaf screening for moisture, ash, and Icariin baseline ≥ 0.8%
Countercurrent Extraction Batteries
Conventional static extraction tanks result in high thermal degradation and solvent overuse. Our partner factory lines deploy continuous dynamic countercurrent extraction batteries operating under automated SCADA supervision. Controlled temperature gradients (55°C to 65°C) and optimized hydroalcoholic ratios (typically 60-70% food-grade ethanol) prevent hydrolysis of heat-sensitive rhamnoside bonds while achieving complete exhaustion of target bioactives within 90 minutes.
- 40% reduction in thermal exposure vs traditional kettle boiling
- Yield consistency within ±0.3% total extracted solids per ton
Macroporous Adsorption Purification
Crude eluates contain tannins, chlorophyll, and polysaccharides that reduce active ingredient purity and lead to hygroscopic, caking powders. We utilize dedicated polymeric macroporous adsorption resin columns (AB-8 and D101 non-polar crosslinked polystyrene matrices). Automated gradient elution removes ballast carbohydrates and inorganic salts, enabling clean concentrations ranging from 10% to 60% Icariin before transferring to vacuum falling film concentrators and cleanroom spray drying towers.
- Zero halogenated resin leakage monitored via Headspace GC
- Direct crystallization line for high-purity Icariin ≥ 98.0%
Technical Roadmap: Enzymatic Biotransformation & Nano-Formulation
Leading the structural transition from low-bioavailability glycosides to highly active aglycones and precision-delivered pharmaceutical intermediates.
Enzymatic Cleavage to Icariside II
Natural Icariin has modest oral bioavailability due to high molecular weight and steric hindrance of its dual sugar chains. Our forward-looking process incorporates recombinant beta-glucosidase enzymatic bioreactors. By selectively cleaving the glucose moiety at the C-7 position while leaving the C-3 rhamnose intact, Icariin converts to Icariside II (Baohuoside I) with conversion yields exceeding 92%. Icariside II demonstrates an 8-fold increase in intestinal membrane permeability (Caco-2 models) and an order-of-magnitude higher binding affinity for target PDE5 enzymes.
Hydrolysis Yield ≥ 92.5%Preparative HPLC for Pure Icaritin
For oncology and targeted hormone-receptor therapeutics, the aglycone Icaritin (C21H20O6) has emerged as a groundbreaking clinical candidate. Through complete acid or enzymatic deglycosylation followed by preparative axial-compression column chromatography, our factories isolate 98.0% to 99.0% pharmaceutical-grade Icaritin. This fine chemical intermediate operates as an immunological and dual-estrogen receptor modulator (ERα36 inhibition) without the mutagenic off-target profiles associated with synthetic small molecules.
Purity ≥ 98.5% (HPLC-DAD)Subcritical Fluid Cosolvent Extraction
To satisfy stringent organic solvent restrictions in the European Union, we have pioneered subcritical water and supercritical CO2 extraction systems utilizing 5-8% ethanol as an entrainer. Operating between 150 and 280 bar, this clean-label extraction pathway leaves zero chemical solvent residues, preserves thermolabile volatile fractions, and produces completely solvent-free, non-denatured Epimedium powder meeting EFSA pristine botanical criteria.
Zero Toxic Residue GuaranteeLiposomal & Self-Emulsifying (SEDDS)
Standard Epimedium powder displays limited water solubility and poor dispersion in ready-to-drink functional beverages and modern gummy matrices. Our formulation engineering R&D offers modified physical grades: microencapsulated liposomal powders and Self-Emulsifying Drug Delivery Systems (SEDDS). These high-tech formats create transparent, thermodynamically stable microemulsions upon hydration, ensuring rapid gastric transit and bypassing first-pass hepatic glucuronidation.
100% Cold-Water Clear SolutionMacro-Industry Applications & Targeted Solutions
Strategic biochemical integration pathways for global nutraceutical brands, clinical therapeutics, sports performance products, and longevity formulators.
Men's Endothelial & Vitality Formulations
Icariin serves as a selective, competitive inhibitor of cGMP-specific phosphodiesterase type 5 (PDE5). By attenuating the degradation of cyclic GMP and stimulating endothelial nitric oxide synthase (eNOS) expression, standardized Epimedium extracts restore microvascular perfusion. Enterprise formulators frequently combine our 20% to 50% Icariin grades with L-Citrulline, Panax Ginseng, and Ajuga Turkestanica for clinically proven vascular, nitric oxide, and stamina blends.
- cGMP-Specific PDE5 inhibition kinetics
- Non-hormonal testosterone pathway stimulation
Bone Mineral Density & Osteoporosis Care
Age-related estrogen deficiency accelerates trabecular bone loss. Icariin and Epimedin C stimulate osteoblast proliferation and alkaline phosphatase (ALP) activity via the canonical BMP-2/Smad4 and Wnt/β-catenin signaling cascades while downregulating osteoclastogenesis through the OPG/RANKL axis. Our water-dispersible Epimedium grades are incorporated alongside Microcrystalline Hydroxyapatite and Vitamin K2 (MK-7) in prescription joint and bone matrices worldwide.
- Stimulates Runx2 & BMP-2 osteogenic markers
- Demonstrated preservation of trabecular architecture
Neuroprotective & Cognitive Therapeutics
Neuroinflammation and hyperphosphorylated tau accumulation drive neurodegenerative decline. Icariin easily crosses the blood-brain barrier (BBB) to attenuate amyloid-β (Aβ1-42) oligomer neurotoxicity, inhibit beta-secretase (BACE1), and upregulate Brain-Derived Neurotrophic Factor (BDNF). Formulators integrate our high-purity Epimedium extract with Rhodiola Rosea and Grape Seed Extract (GSE) for advanced nootropic and cognitive preservation complexes.
- Mitigates microglial NF-κB inflammatory cascades
- Modulates hippocampal synaptic plasticity & LTP
Anti-Photoaging & Dermato-Cosmetics
Dermal fibroblasts subjected to ultraviolet (UVA/UVB) radiation experience massive reactive oxygen species (ROS) spikes, upregulating matrix metalloproteinases (MMP-1 and MMP-3) which destroy extracellular collagen. The C-5 and C-7 phenolic hydroxyl groups of Icaritin and Icariin neutralize hydroxyl radicals and inhibit AP-1 signaling, preserving procollagen type I synthesis. Our decolorized, low-odor grades are formulated in high-end cosmetic serums and firming creams.
- MMP-1 collagenase suppression ≥ 68% in vitro
- Decolorized, non-staining topically compatible powders
Standard Industrial Epimedium Extract Grade Matrix
Verified chromatographic specifications engineered to fit high-speed automated capsule filling, direct tablet compression, liquid suspension, and research-grade synthesis.
| Commercial Grade | Marker Assay (HPLC/UV) | Physical Form & Color | Bulk Density | Key Formulation Application |
|---|---|---|---|---|
| Icariin 10% Standard | ≥ 10.0% Icariin (HPLC) | Fine Brownish-Yellow Powder | 0.45 - 0.55 g/mL | Cost-effective bulk dietary supplements, softgels, and multi-herbal vitality complexes. |
| Icariin 20% Standard | ≥ 20.0% Icariin (HPLC) | Fine Light Brown Powder | 0.48 - 0.58 g/mL | Standard clinical strength capsules, pre-workout vasodilators, and joint health blends. |
| Icariin 50% Potency | ≥ 50.0% Icariin (HPLC) | Light Yellow Crystalline Powder | 0.50 - 0.60 g/mL | High-potency micro-tablets, premium vitality supplements, and targeted bone density tablets. |
| Icariin 98% Ultra-Pure | ≥ 98.0% Icariin (HPLC-DAD) | Pure Light Yellow Needle Crystal | 0.35 - 0.45 g/mL | Analytical reference standard, pharmaceutical research, and enzymatic synthesis starting material. |
| Icariside II 98% (Baohuoside I) | ≥ 98.0% Icariside II (HPLC) | Off-White / Pale Yellow Powder | 0.40 - 0.50 g/mL | High-bioavailability next-gen male wellness, rapid-action sublingual tablets, and clinical patents. |
| Icaritin 98% Aglycone | ≥ 98.0% Icaritin (HPLC-DAD) | Light Greenish-Yellow Powder | 0.38 - 0.48 g/mL | Oncology therapeutic research, selective estrogen receptor studies, and targeted API pipelines. |
| Water-Soluble Flavonoids | ≥ 20.0% Total Flavonoids | 100% Water-Soluble Amber Powder | 0.52 - 0.62 g/mL | Ready-to-drink (RTD) functional beverages, effervescent vitality powders, and modern functional gummies. |
Analytical Release Protocols & Regulatory Compliance
Full regulatory dossier transparency. Every lot is released through independent chromatographic and spectroscopic validation aligned with USP, EP, and FDA cGMP criteria.
Pesticide Residue Limits (USP <561>)
Epimedium species harvested from wild mountain terrain risk exposure to drift contaminants. Our quality release screens exceed 450 pesticide active residues via GC-MS/MS and LC-MS/MS triple-quadrupole instruments. We guarantee compliance with USP <561> and Regulation (EC) No 396/2005, enforcing zero tolerance for organochlorines, organophosphates, pyrethroids, and ethylene oxide (ETO/2-CE < 0.05 mg/kg).
USP <561> & EU EC 396/2005 CompliantHeavy Metals Screening (ICP-MS)
Natural geo-accumulation of elemental impurities in wild Berberidaceae foliage requires rigorous multi-point testing. Utilizing Agilent 7800 ICP-MS hardware with collision cell technology, our laboratory tests each commercial batch for the "Big Four" toxic elements: Lead (Pb < 1.0 ppm), Arsenic (As < 1.0 ppm), Cadmium (Cd < 0.5 ppm), and Mercury (Hg < 0.1 ppm), conforming with California Proposition 65 and European Commission Regulation (EU) 2023/915.
ICP-MS Validated · California Prop 65 ReadyMicrobiology & Absence of Adulteration
Biological integrity is assured via automated cleanrooms and post-extraction pasteurization. All batches comply with USP <2021> and <2022> microbial limits: Total Aerobic Microbial Count (TAMC ≤ 1,000 CFU/g), Total Yeast and Mold (TYMC ≤ 100 CFU/g), and verified absent for Salmonella spp., Escherichia coli, and Staphylococcus aureus. Furthermore, HPLC-DAD fingerprinting checks confirm the total absence of synthetic PDE5 inhibitor adulterants (Sildenafil, Tadalafil, Vardenafil analogs).
Non-Irradiated · Zero Synthetic AdulterantsAnalytical Testing Laboratory Equipment
Our partner factory labs operate high-performance separation and spectroscopic hardware to authenticate compound stability, residual solvents, and botanical identity before packaging release.
Epimedium Extract Procurement & Formulation FAQ
Direct engineering answers for supply chain executives, analytical chemists, regulatory specialists, and contract manufacturers.
What are the exact pharmacopeial standards used to quantify Icariin content in raw extracts?
How does your factory prevent cross-contamination or adulteration with synthetic PDE5 inhibitors?
What solvent extraction profile is utilized, and how are residual solvents mitigated?
Can you support custom mesh size, bulk density, and granulation requirements for direct compression?
Which regulatory documentation package accompanies commercial production batches?
What are the minimum order quantities (MOQ) and production lead times for custom potencies?
Complementary Standardized Extracts & Actives
Expand your formulation pipeline with active ingredients processed in the same certified industrial manufacturing plants. Batch tested and internationally documented.
China Rhodiola Rosea Extract Suppliers, Factory
View Specifications
Best Ginseng Extract Suppliers, Factories
View Specifications
Wholesale Epimedium Extract Suppliers, Factory
View Specifications
China Quercetin Suppliers, Factories
View Specifications
Best Grape Seed Extract (GSE) Supplier, Factory
View Specifications
Best Olive Leaf Extract Exporter, Exporters
View Specifications
Best Ajuga Extract Suppliers, Exporters
View Specifications
China Broccoli Seed Extract Factories, Exporter
View SpecificationsMost Requested Botanical Ingredients & Specifications
Direct technical links to active ingredient dossiers and standard manufacturer release grades:
Qualifying an Epimedium Extract Factory Partner?
Directly connect with our industrial extraction engineering and quality control team. Request complete Certificates of Analysis (COA), analytical HPLC chromatograms, standard operating procedures, and qualification sample batches.